79 related articles for article (PubMed ID: 29100455)
1. Clinical validation of genetic variants associated with
Fasching PA; Häberle L; Rack B; Li L; Hein A; Ekici AB; Reis A; Lux MP; Cunningham JM; Ruebner M; Jenkins G; Fridley B; Schneeweiss A; Tesch H; Lichtenegger W; Fehm T; Heinrich G; Rezai M; Beckmann MW; Janni W; Weinshilboum RM; Wang L
Oncotarget; 2017 Sep; 8(44):78133-78143. PubMed ID: 29100455
[TBL] [Abstract][Full Text] [Related]
2. Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.
Kadalayil L; Khan S; Nevanlinna H; Fasching PA; Couch FJ; Hopper JL; Liu J; Maishman T; Durcan L; Gerty S; Blomqvist C; Rack B; Janni W; Collins A; Eccles D; Tapper W
Nat Commun; 2017 Nov; 8(1):1632. PubMed ID: 29158497
[TBL] [Abstract][Full Text] [Related]
3. Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer.
Zhang J; Wang L; Wang Z; Wang B; Cao J; Lv F; Zhang S; Shao Z; Hu X
Oncotarget; 2017 Oct; 8(45):79527-79536. PubMed ID: 29108332
[TBL] [Abstract][Full Text] [Related]
4. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M; Luo W; Karlsson P; Chirgwin J; Aebi S; Jerusalem G; Neven P; Hitre E; Graas MP; Simoncini E; Kamby C; Thompson A; Loibl S; Gavilá J; Kuroi K; Marth C; Müller B; O'Reilly S; Di Lauro V; Gombos A; Ruhstaller T; Burstein H; Ribi K; Bernhard J; Viale G; Maibach R; Rabaglio-Poretti M; Gelber RD; Coates AS; Di Leo A; Regan MM; Goldhirsch A;
Lancet Oncol; 2018 Jan; 19(1):127-138. PubMed ID: 29158011
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Wakelee HA; Dahlberg SE; Keller SM; Tester WJ; Gandara DR; Graziano SL; Adjei AA; Leighl NB; Aisner SC; Rothman JM; Patel JD; Sborov MD; McDermott SR; Perez-Soler R; Traynor AM; Butts C; Evans T; Shafqat A; Chapman AE; Kasbari SS; Horn L; Ramalingam SS; Schiller JH;
Lancet Oncol; 2017 Dec; 18(12):1610-1623. PubMed ID: 29129443
[TBL] [Abstract][Full Text] [Related]
6. Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Rimawi MF; De Angelis C; Contreras A; Pareja F; Geyer FC; Burke KA; Herrera S; Wang T; Mayer IA; Forero A; Nanda R; Goetz MP; Chang JC; Krop IE; Wolff AC; Pavlick AC; Fuqua SAW; Gutierrez C; Hilsenbeck SG; Li MM; Weigelt B; Reis-Filho JS; Kent Osborne C; Schiff R
Breast Cancer Res Treat; 2018 Feb; 167(3):731-740. PubMed ID: 29110152
[TBL] [Abstract][Full Text] [Related]
7. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer.
Araujo-Mino EP; Patt YZ; Murray-Krezan C; Hanson JA; Bansal P; Liem BJ; Rajput A; Fekrazad MH; Heywood G; Lee FC
Oncologist; 2018 Jan; 23(1):2-e5. PubMed ID: 29158365
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.
Seto T; Hirai F; Saka H; Kogure Y; Yoh K; Niho S; Fukase K; Shimada H; Sasai M; Fukino K
Jpn J Clin Oncol; 2018 Jan; 48(1):31-42. PubMed ID: 29136201
[TBL] [Abstract][Full Text] [Related]
9. Systemic therapy for esophageal cancer: chemotherapy.
Ku GY
Chin Clin Oncol; 2017 Oct; 6(5):49. PubMed ID: 29129089
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
Niravath P; Chen B; Chapman JW; Agarwal SK; Welschhans RL; Bongartz T; Kalari KR; Shepherd LE; Bartlett J; Pritchard K; Gelmon K; Hilsenbeck SG; Rimawi MF; Osborne CK; Goss PE; Ingle JN
Clin Breast Cancer; 2018 Feb; 18(1):78-87. PubMed ID: 29128193
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
Jabs V; Edlund K; König H; Grinberg M; Madjar K; Rahnenführer J; Ekman S; Bergkvist M; Holmberg L; Ickstadt K; Botling J; Hengstler JG; Micke P
PLoS One; 2017; 12(11):e0187246. PubMed ID: 29112949
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared remotely triggered drug-release strategies for cancer treatment.
Goodman AM; Neumann O; Nørregaard K; Henderson L; Choi MR; Clare SE; Halas NJ
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12419-12424. PubMed ID: 29109274
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis.
Leung HWC; Leung JH; Chan ALF
Expert Opin Drug Saf; 2018 Jan; 17(1):1-7. PubMed ID: 29108432
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.
Zhang F; LingHu R; Zhan X; Li R; Feng F; Gao X; Zhao L; Yang J
Oncotarget; 2017 Oct; 8(45):80020-80028. PubMed ID: 29108384
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model.
Faugeroux V; Pailler E; Oulhen M; Deas O; Brulle-Soumare L; Hervieu C; Marty V; Alexandrova K; Andree KC; Stoecklein NH; Tramalloni D; Cairo S; NgoCamus M; Nicotra C; Terstappen LWMM; Manaresi N; Lapierre V; Fizazi K; Scoazec JY; Loriot Y; Judde JG; Farace F
Nat Commun; 2020 Apr; 11(1):1884. PubMed ID: 32313004
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.
Fasching PA; Liu D; Scully S; Ingle JN; Lyra PC; Rack B; Hein A; Ekici AB; Reis A; Schneeweiss A; Tesch H; Fehm TN; Heinrich G; Beckmann MW; Ruebner M; Huebner H; Lambrechts D; Madden E; Shen J; Romm J; Doheny K; Jenkins GD; Carlson EE; Li L; Fridley BL; Cunningham JM; Janni W; Monteiro ANA; Schaid DJ; Häberle L; Weinshilboum RM; Wang L
Clin Cancer Res; 2022 Aug; 28(15):3342-3355. PubMed ID: 35653140
[TBL] [Abstract][Full Text] [Related]
18. Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
Wunderle M; Olmes G; Nabieva N; Häberle L; Jud SM; Hein A; Rauh C; Hack CC; Erber R; Ekici AB; Hoyer J; Vasileiou G; Kraus C; Reis A; Hartmann A; Schulz-Wendtland R; Lux MP; Beckmann MW; Fasching PA
Geburtshilfe Frauenheilkd; 2018 May; 78(5):481-492. PubMed ID: 29880983
[TBL] [Abstract][Full Text] [Related]
19. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers.
Taran FA; Schneeweiss A; Lux MP; Janni W; Hartkopf AD; Nabieva N; Overkamp F; Kolberg HC; Hadji P; Tesch H; Wöckel A; Ettl J; Lüftner D; Wallwiener M; Müller V; Beckmann MW; Belleville E; Wallwiener D; Brucker SY; Fasching PA; Fehm TN; Schütz F
Geburtshilfe Frauenheilkd; 2018 Mar; 78(3):237-245. PubMed ID: 29576629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
